Enzymedica Berberine Phytosome 275 mg Vegan Suitable Not Kosher Certified Description:

- PURITY PROMISE: Contains no gluten, milk, casein, soy, egg, artificial colors, flavors, or GMOs. 100% Vegan
- ULTRA ABSORPTION TECHNOLOGY: Berbevis® Phytosome offers 9.6x better absorption than standard Berberine extracts
- BLOOD SUGAR METABOLISM*: Supports healthy metabolism of blood sugar already within normal range*
- HEALTHY BODY COMPOSITION*: Benefits for normal metabolism and body composition.*
- HEART, CARDIOVASCULAR AND IMMUNE HEALTH*: Naturally occurring plant alkaloids promote healthy cardiovascular and immune system function~
- SMALL, EASY-TO-SWALLOW CAPSULE: Phytosome technology unlocks greater potency in a lower dose and smaller capsule
What Is Berberine?
Berberine is an alkaloid found in plants like Goldenseal, Barberry, Oregon Grape and Goldthread.
This alkaloid has long been used as a natural way to support a number of common ailments, boost blood sugar metabolism and promote healthy weight loss.* Modern research now bolsters what common wisdom told us long ago about Berberine.
What Makes Enzymedica’s Berberine Phytosome Better?
Enzymedica’s® Berberine Phytosome uses ultra-absorption phytosome technology. Since Berberine can be difficult for the body to absorb, it is harder to unlock its true benefits.
Berbevis® phytosome solves this problem – boosting bioabsorption 9.6 times compared with standard raw extracts. This unlocks greater potency at a lower dose, allowing for a small, easy-to-swallow capsule.
Enzymedica’s Berberine Phytosome uses lower doses of Berberine so that it is easier to digest than other forms of Berberine that could cause stomach upsets.
There are numerous research studies that support Berberine’s use as a dietary supplement. In a series of two double-blind studies, Berberine was found to be influential for healthy weight management.*1,2
- Yang, J., Yin, J., Gao, H., Xu, L., Wang, Y., and Li, M. Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients. Evid. Based Complement. Altern. Med. 2012; 2012: 363845.
- Perez-Rubio, K.G., Gonzalez-Ortiz, M., Martinez-Abundis, E., Robles-Cervantes, J.A., and Espinel-Bermudez, M.C. Effect of Berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab. Syndr. Relat. Disord. 2013; 11: 366–369.
Disclaimer:
These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent
any disease.